Crinetics Pharmaceuticals Inc
(CRNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 399 | 640 | 0 | 346 | 988 |
| Gross Profit | 399 | 640 | 0 | 346 | 988 |
| Operating Expenses | 83,182 | 74,169 | 62,658 | 59,323 | 53,983 |
| Operating Income | -82,783 | -73,529 | -62,658 | -58,977 | -52,995 |
| Other Income | 8,728 | 6,599 | 2,561 | 1,519 | 2,016 |
| Pre-tax Income | -74,055 | -66,930 | -60,097 | -57,458 | -50,979 |
| Net Income Continuous | -74,055 | -66,930 | -60,097 | -57,458 | -50,979 |
| Net Income | $-74,055 | $-66,930 | $-60,097 | $-57,458 | $-50,979 |
| EPS Basic Total Ops | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 |
| EPS Basic Continuous Ops | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 |
| EPS Diluted Total Ops | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 |
| EPS Diluted Continuous Ops | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -0.93 | -0.90 | N/A | N/A |
| EBITDA(a) | $-85,438 | $-76,902 | $-65,980 | $-59,950 | $-53,626 |